Views Navigation

Event Views Navigation

Today

HIVLN – Positive Health Access to Services and Treatment (PHAST) Program: Past, Present and Future of Rapid Response and Engagement/Re-Engagement in HIV Treatment and Care

Zoom

Register   Join us for the next HIV Learning Network session on October 13 @ Noon (Pacific): Positive Health Access to Services and Treatment (PHAST) Program: Past, Present and Future of Rapid Response and Engagement/Re-Engagement in HIV Treatment and Care​, by Sandra Torres, MSW, PHAST/RAPID Social Worker, Ward 86, USCF. Description: Rapid response to new HIV diagnoses is national […]

HIVLN – HIV and Harm Reduction: A Cultural Approach

Zoom

Register Join us for the next HIV Learning Network session on December 8 @ Noon (Pacific): HIV and Harm Reduction: A Cultural Approach​​, by Gigi J. Simmons, MD, Clinical Educator, Department of Family Medicine, Charles R. Drew University of Medicine and Science. Description: Harm reduction strategies help to lessen the harms associated with drug use and related behaviors to increase […]

HIV Learning Network: HIV and the Nervous System

Zoom

Register Join us for the next HIV Learning Network session on January 12 @ Noon (Pacific): HIV and the Nervous System​​, by Guy Vandenberg, MSW, ACRN, Faculty, HIV Learning Network, Pacific AETC Description: As opportunistic infections (OIs) have become less common with the advancement of HIV antiretroviral therapy, providers may have less exposure to patients presenting neurological disorders associated with advanced HIV […]

HIV Learning Network: What’s New in the Updated 2022 Recommendations of the IAS-USA Panel on Antiretroviral Treatment

Zoom

Register Join us for the next HIV Learning Network session on January 26 @ What’s New in the Updated 2022 Recommendations of the IAS-USA Panel on Antiretroviral Treatment​​​, by Daniel Lee, MD, AAHIVS, Clinical Professor of Medicine, Owen Clinic, UCSD Description: On December 1, 2022, the International Antiviral Society - USA (IAS-USA) Panel released it's updated HIV Antiretroviral Treatment […]